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Morawitz (1904) originally suggested, and Eagle and Harris (1937) have pre- 
sented considerable  evidence that, in the course of physiological coagulation, 
calcium  plus  thromboplastic substance  constitute an enzyme system, analo- 
gous to trypsin and to several other proetolytie enzymes.  This enzyme system 
is believed to be responsible for the transformation of prothrombin to throm- 
bin, which  itself is thought to be a proteolytic enzyme that accelerates  the 
transformation of fibrinogen to fibrin (as first suggested by Schmidt, 1892). 
In view of the evidence for this mechanism, it was suspected that serum anti- 
protease might normally play some rSle in the process of coagulation.  This 
was investigated by studying the effect on coagulation not only of purified 
serum antiprotease (prepared  after the method of Schmitz  (1938), which pro- 
vided a yield of 40 nag. from 5 liters of pig's blood), but also of crystalline pan- 
creatic  trypsin inhibitor  (prepared  from beef pancreas  after Northrop  and 
Kunitz (1932-33)), which is believed by Schmitz to be almost identical with 
the serum compound, and which can be obtained in far greater amounts. 
The effect of varying amounts of 0.5 per cent solutions of these preparations 
(at neutral pH) on the clotting time of oxalated rabbit's plasma, recalcified 
with an optimum amount of Ca  ++ (as determined in Table I), is recorded  in 
Table II.  The clotting time was taken at 37°C. as the time between the addi- 
tion of the Ca  ++. and the formation of a clot firm enough not to move down 
standard Wassermann tubes (run in duplicate) when these were inverted.  It 
is seen that some substance in these preparations is capable  of markedly in- 
creasing the coagulation time.  Control tubes showed that ammonium sulfate, 
from which the preparations could not be entirely freed, was not important in 
this respect. 
Table III describes the effect of adding increasing amounts of crude trypsin 
to plasma to which serum antitrypsin or pancreatic trypsin inhibitor had been 
added, and the resulting solution allowed to stand for 15 minutes before the 
addition of Ca  ++.  (It was found that a time interval elapsed before the anti- 
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coagulant action was complete.)  It is observed that the effect of the trypsin 
was to progressively neutralize the effect of the trypsin inhibitor preparation. 
TABLE I 
Optimum Concentration of Ca  ++ 
0.5 per cent  0.5 per cent  Oxalated  1 per cent  Pancreatic  0.1 per cent  0.85  per cent  Coagulation  Serum  plasma  CaCh  trypsin  antitrypsin  Crude trypsin  NaCI  time 
inhibitor 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
CC.  ¢.C.  CC.  6. 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
m/n. 
o0 
cO 
5.2 
4.0 
6.8 
9.1 
TABLE II 
Anticoagulant Action of Purified A ~iprote~e 
i 
0.5  per cent  0.5 per cent  0.I  per cent  0.85  per cent  Coagulation 
0xalated  !  per cent  Pancreatic  Serum  Crude trypsin  NaCl  time  plasma  CaCh  trypsin  antitrypsin  inhibitor 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
0.3 
0.3 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
0.3 
0.3 
CC. 
0.0 
0.05 
0.1 
0.2 
0.3 
0.4 
0.5 
m 
D 
CC. 
0.0 
0.1 
0.2 
0.3 
0.35 
0.4 
cc. 
I 
m 
B 
m 
6° 
0.5 
0.45 
0.4 
0.3 
0.2 
0.1 
0.0 
0.4 
0.3 
0.2 
0.1 
0.05 
0.0 
m/n. 
4.0 
5.1 
6.3 
9.0 
22 
57 
20 hrs. 
4.5 
6.0 
8 
11 
20 
120 
Table IV serves as a  control to  show that  the addition of trypsin (in the 
amounts employed) to oxalated plasma plus Ca  ++ of itself only slightly accel- 
erates  coagulation.  Hence  the  effect  of  trypsin  described  above  must  be 
chiefly a  specific neutralizing (or destructive?) effect on the anticoagulant. 
The addition of trypsin to  oxalated or citrated plasma is known to  cause 
coagulation.  In Table V  is described the effect of adding increasing amounts 
of trypsin inhibitor to the oxalated plasma plus trypsin.  This is seen to have DAVID GROB  425 
resulted  in a  progressive  increase  in the  time  required  for the plasma  to co- 
agulate. 
These experimental  results strongly indicate that a  sufficient concentration 
of  serum  antitrypsin  or pancreatic  trypsin  inhibitor,  prepared  as  indicated 
above,  strongly  inhibits  the  coagulation  of  plasma  in  vitro.  This  effect  is 
largely prevented  by  the  addition  of trypsin.  That  an  anticoagulant  other 
TABLE III 
Neutralizing A orion of Trypsin on the A nticoagulant 
0.5 per cent 
Oxalated  1 per cent  Pancreatic  0.5 per cent  plasma  CaCh  trypsin  Serum  0.t per cent  0.85 per cent  Coagulation 
inhibitor  antitrypsin Crude  trypsin  NaCI  time 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
CC. 
0.3 
0.3 
0.3 
0.3 
0.3 
m 
m 
CC. 
0.3 
0.3 
0.3 
0.3 
CC. 
0.0 
0.05 
0.1 
0.2 
0.3 
0 
0.1 
0.2 
0.3 
GC. 
0.3 
0.25 
0.2 
0.1 
0.0 
0.3 
0.2 
0.1 
0.0 
ra/n. 
24 
18 
14 
12 
10 
11 
11 
9 
5.5 
TABLE IV 
Non-Influence of 0.1 Per Cent Trypsin on Coagulation by Ca  ++ 
0.5  per  cent 
Oxalated  1 per cent  Pancreatic  0.5 per cent  0.1 per cent  0.85  per cent  Coagulation 
plasma  CaCh  trypsin  Serum  Crude trypsin  NaCI  time 
inhibitor  antitrypsin 
0.5 
0.5 
0.5 
0.5 
CC. 
0.5 
0.5 
0.5 
0.5 
CC.  CC.  CC. 
0.0 
0.1 
0.2 
0.3 
0.3 
0.2 
0.1 
0.0 
m/n. 
4 
4 
3.8 
3.6 
than  a  trypsin inhibitor was present  in one or both of the preparations  is of 
course possible, but is contraindicated by the neutralizing effect of trypsin. 
In an attempt to determine the mode of action of the anticoagulant varying 
amounts of pancreatic trypsin inhibitor were added to thrombin (prepared by 
adding thromboplastin (after Mills and Guest, 1921) and Ca  ++ to prothrombin 
(after Mellanby,  1931)),  a  time interval of 15 minutes allowed to elapse, and 
fibrinogen  (salted from plasma with sodium chloride)  added.  Table VI indi- 
cates  the  absence  of any appreciable  antithrombic  effect by the  trypsin  in- 
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The  "antiprothrombic"  effect of pancreatic  trypsin  inhibitor was  investi- 
gated by adding varying amounts  to prothrombin plus thromboplastin,  and 
adding calcium after  15  minutes.  Then,  after 2,  5,  and  10 minutes a  given 
Oxalated 
plasma 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
0.3 
TABLE V 
Neutralization of Tryptic Action by Purified A nti 
l  per cent 
CaCh 
C¢. 
m 
B 
B 
B 
m 
0.5 per cent 
Pancreatic 
trypsin 
inhibitor 
CC. 
0 
0.1 
0.2 
0.3 
0.4 
0,5 per cent 
Serum 
antitrypsln 
CO. 
0 
0.1 
0.2 
0.3 
0.4 
0.1per cent 
Crude trypsin 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
~fotcase 
0.85 per cent 
NaCI 
~° 
0.4 
0.3 
0.2 
0.1 
0 
0.4 
0.3 
0.2 
0.1 
0 
Coagulation 
time 
mln. 
9 
10 
12 
14 
17 
8 
8 
9 
10 
13 
TABLE VI 
Lack of A ntitkrombic A ctivity of Trypsin Inhibitor 
Fibrinogen  Thrombin  0.5 per cent 
(in 0.85 per cent  (in 0.85 per cent  Pancreatic trypsin  0.85 per cent NaCI  Coagulation  time 
NaCI)  NaC1)  inhibitor 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.4 
0.3 
0.2 
0.1 
CC. 
0.3 
0.4 
0.5 
0.6 
m/n. 
2.6 
3.1 
5.0 
11 
0.05 
0.4 
0.3 
0.2 
0.1 
0.05 
0.3 
0.3 
0.3 
0.3 
0.3 
0.65 
0 
0.1 
0.2 
0.3 
0.35 
30 
3.0 
3.5 
5.4 
10 
32 
amount of each mixture was tested for thrombic activity (Mellanby, 1917) by 
adding it to a  solution of fibrinogen and determining the time that elapsed be- 
fore coagulation took place.  Table VII shows that the trypsin inhibitor mark- 
edly inhibited  the  conversion of prothrombin  to  thrombin  by  the action of 
thromboplastin plus Ca  ++.  Whether it did so by acting on the prothrombin, or DAVID  GROB  427 
thromboplastin,  or  both,  was  not  experimentally  determined.  But  if  the 
mechanism of coagulation described above is even partly correct, action on the 
thromboplastin is strongly  indicated.  That  the inhibitor does not act by re- 
ducing the concentration of ionized calcium was easily proved by demonstrat- 
ing that the presence of excess Ca  ++ would not neutralize the effect of the anti- 
coagulant.  In  fact,  it  resulted  in  a  further  prolongation  of  the  coagula- 
tion time. 
Various workers have suggested that  in addition  to their probable r61e in 
the coagulation process proteolytic enzymes are responsible for thrombinolysis, 
TABLE VII 
A ntiprotkrombic Activity of Trypsin Inlgbitor 
Prothrombin 
(in 0.85 per cent 
0.5  A 
B 
Fibrinogen 
cG. 
0.5 q- 0.1 cc. of A after  2 rain. 
0.5 q- 0.1 cc. of A after  5 rain. 
0.5 q- 0.1 cc. of A after 10 rain. 
0.5 q- 0.1 cc. of B after  2 rain. 
0.5 q- 0.1 cc. of B after  5 rain. 
0.5 -[- 0.1 cc. of B after 10 rain. 
Thrombo-  0.5 per cent 
1 per cent  plastin (in 0.85  Pancreatic 
per cent  trypsin 
CaCh  NaCI)  inhibitor 
t-/ 
0.1  0.1  0 
0.1  0.1  0.3 
0.85~ent 
CC. 
0.3 
0 
ir,  cubation ............................. 
incubation ............................. 
incubation ............................. 
of incubation .......................... 
of incubation .......................... 
of incubation .......................... 
Coagulation 
time 
50 
24 
3 
> 24 hrs. 
120 rain. 
10 rain. 
fibrinolysis, and syneresis.  Inhibition by purified antiprotease would  afford 
evidence that proteases are involved in these processes. 
Hemophilia 
Almost all the current theories on the etiology of hemophilia agree in attrib- 
uting the prolonged coagulation time observed in this condition to a  delay in 
the formation of thrombin.  That a  deficiency of active thromboplastic sub- 
stance may be the cause of this is indicated by the fact that hemophilie blood 
can be made to coagulate in normal time by adding additional platelets (nor- 
mal or hemophilic), or by adding trypsin (Tyson and West,  1937;  Ferguson 
and Erickson,  1939).  In view of these findings, and of the evidence of Addis 
(1911) and of Eagle (1935) that the platelets and prothrombin content of hemo- 
philic blood are normal, the possibility that an inhibitor of thromboplastin is 
responsible for the  delayed activation of prothrombin  to  thrombin must be 
considered. 
Evidence that,  if such a  thromboplastin inhibitor is present in hemophilic 428  ANTIPROTEOLYTIC  ACTMTY  OF  SERUM.  IX 
blood, it does not possess antiproteolytic activity, was supplied by examination 
of the plasma and serum of two hemophiliacs (one of whom was studied through 
the courtesy of Dr. W. H. Howell).  In both of these the antiproteolytic activ- 
ity was in the normal range, despite greatly prolonged coagulation time. 
Heparin 
If we assume serum antiprotease to be a circulating anticoagulant the possi- 
bility of its identity with one of the known circulating anticoagulants must be 
considered. 
It has been found by independent investigators that anaphylactic shock or 
peptone injection results in an appreciable increase in the antithrombin con- 
tent of the serum as well as in its antiproteolytic activity (Jobling, Petersen, 
and Eggstein,  1915).  In addition, both antithrombic (Mellanby,  1908) and 
TABLE VIII 
Before  heparinization  ......................... 
During heparinizafion  ........................ 
(Later) during heparinization  .................. 
Dog 1 
Coagula-  Antiproteo, 
lytic  tion time  activity 
rain.  S  units/c¢. 
20  3.6 
115  3.8 
45  3.2 
Dog 2 
Coagula-  Antiproteo- 
lyric  tion time  activity 
rain.  S  units/co. 
17  4.5 
90  4.1 
53  4.6 
antiproteolytic activity (Fujimoto, 1918) are destroyed by heating plasma or 
serum at 75 ° for 10 minutes.  However, that antiprotease and antithrombin 
are separate entities is indicated by the experiments of Mellanby and Pratt 
(1938),  and by the evidence presented above that pancreas trypsin inhibitor 
has little or no antithrombic activity. 
Recently Jaques and Waters (1940) have shown that heparin is also increased 
in peptone  shock, while other investigators (Glazko and Ferguson,  1940, and 
Horwitt,  1940) have found that heparin,  in sufficient concentration, inhibits 
the action of trypsin.  However, some evidence against the identity of heparin 
and serum antiprotease is supplied by the finding that heparinization does not 
increase the antiproteolytic activity of the blood. 
The blood of two heparinized dogs was followed in the Hunterian laboratory 
through the courtesy of Dr. H. B. Schumacker.  Table VIII illustrates the lack 
of any relation found between the heparin content of the blood (as indicated 
by the clotting time) and the antiproteolytic activity of the serum.  (The anti- 
proteolytic activity of plasma and of serum are normally equal.)  The serum DAVID GROB  429 
of the heparinized blood was allowed to remain in contact with the alkaline 
trypsin (crude) for 30 minutes before the casein was added, as suggested by 
Horwitt.  This is a condition which is not ordinarily necessary for the antipro- 
teolytic action of serum.  Additional experiments showed that the inhibiting 
action of purified heparin on crude trypsin is much less than the action de- 
scribed by Horwitt on crystalline trypsin.  Serum, on the other hand, is equally 
active against the crude and the crystalline enzyme.  Furthermore, as Tyson 
and West (1937) have shown, trypsin does not accelerate the coagulation of 
heparinized blood, while it has been known to hasten the clotting of oxalated or 
citrated blood. 
These considerations indicate that while a relatively high concentration of 
heparin may, in vitro, have some antitryptic activity, it is probably not responr 
sible for an appreciable part of the antitryptic activity of the serum. 
Horwitt has made the interesting observation that many basic dyes which 
are powerful anticoagulants are also antiproteolytic.  As in the case of heparin 
this parallelism deserves investigation. 
SUMMARY 
1.  Serum antitrypsin and pancreatic trypsin inhibitor inhibited the coagula- 
tion of plasma in vitro. 
2.  This could be largely prevented by trypsin. 
3.  The anticoagulant action of the trypsin inhibitor was apparently due  to 
its antiprothrombic action.  It had no appreciable antithrombic action. 
4.  Examination of the blood of two hemophiliacs indicated that the prolonged 
coagulation time of their blood is not due to an excess of trypsin inhibitor. 
5.  Examination of the blood of heparinized dogs indicated that heparin  does 
not appreciably contribute to the antiproteolytic activity of the serum. 
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